Pharmaceutical Glass Packaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Material; By Route of Administration; By Product; By Drug Type; By Region

Description

Global Pharmaceutical Glass Packaging Market Size to Surpass Staggering Value of USD 30 Billion by 2030

Global Pharmaceutical Glass Packaging Market is flourishing because of a spurring demand for glass packaging from the thriving biopharmaceutical industry primarily due to its superior safety, reliability, and compatibility.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Pharmaceutical Glass Packaging Market size by value at USD 19.56 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size to expand at a CAGR of 8.18% reaching a value of USD 30.03 billion by 2030. The Pharmaceutical Glass Packaging Market is propelled by the growing adoption of generic injectable drugs and substantial demand from the biopharmaceutical sector. Pharmaceutical glass, composed primarily of limestone, soda ash, cullet, and sand, incorporates essential elements like barium and zinc to enhance chemical resistance and durability. These properties are crucial for meeting stringent pharmaceutical standards, ensuring drug safety and packaging integrity. The industry's expansion is further fueled by increasing disease prevalence, driving the necessity for reliable glass packaging. The glass packaging shields medications from physical and biological harm while prolonging shelf life. With ongoing sector growth and technological advancements, the demand for pharmaceutical glass packaging is expected to surge during the period in analysis.

By volume, BlueWeave estimated Global Pharmaceutical Glass Packaging Market size at 6.82 million tons in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size by volume is projected to grow at a CAGR of 8.42% reaching the volume of 9.11 million tons by 2030. Effective glass recycling plays a crucial role in meeting the growing demand for sustainable pharmaceutical packaging solutions. The Institute of Scrap Recycling Industries, Inc., highlights that recycled glass can replace 70% of raw materials in new production, enhancing its commodity value. Container glass constitutes 46% of the annual 130 million tons of glass produced, with a global recycling rate of 32%, as reported by Recovery Magazine. It supports the industry's shift toward adopting sustainable practices, leveraging glass's inherent sustainability and material properties.

Opportunity - Increasing focus on developing recyclable or biodegradable glass materials

Glass, renowned for its sustainability and inert properties, remains crucial in pharmaceutical packaging due to its ability to maintain product integrity without chemical interaction. Types such as borosilicate and treated soda-lime glass offer high hydrolytic resistance and suitability for various medical preparations, including aqueous solutions and parenteral medications. Advances in glass formulation and treatment technologies continue to improve durability and environmental compatibility, aligning with industry trends towards eco-friendly solutions. As the demand grows for sustainable packaging alternatives, innovations in recyclable and biodegradable glass materials promise to sustain and expand market growth in pharmaceutical packaging.

Type I Material Most Used in Pharmaceutical Glass Packaging

Global Pharmaceutical Glass Packaging Market comprises Type I, Type II, and Type III material segments. Type I glass material, particularly borosilicate glass, is renowned for its outstanding resistance to chemical reactions, making it highly suitable for preserving parenteral drugs, injectables, and formulations that demand robust chemical durability and stability. Its composition, incorporating boron molecules instead of alkaline oxides, ensures chemical inertness and superior resistance, making it the preferred option for packaging a diverse array of injectables and sensitive treatments. Hence, the type I material segment holds the largest share in Global Pharmaceutical Glass Packaging Market.

Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

Intensifying geopolitical tensions can have a multifaceted impact on Global Pharmaceutical Glass Packaging Market. Uncertainties stemming from geopolitical instability can jeopardize the availability of raw materials crucial for production. Trade barriers, tariffs, and political instability can all inflate costs and fracture supply chains, ultimately impacting market growth and forcing a recalibration of pricing strategies within the pharmaceutical packaging sector. These challenges converge to create a turbulent business environment, hindering market dynamics and dampening growth prospects for both domestic manufacturers and international suppliers operating within the healthcare sector.

Competitive Landscape

Global Pharmaceutical Glass Packaging Market is fragmented, with numerous players serving the market. The key players dominating Global Pharmaceutical Glass Packaging Market include Corning Incorporated, Nipro Corporation, Shandong Medicinal Glass Co., Ltd, Bormioli Pharma S.p.A., Owens-Illinois, Inc., SGD S.A., Stoelzle Oberglas GmbH, Gerresheimer AG, West Pharmaceutical Services, Inc., Piramal Enterprises Ltd, Arab Pharmaceutical Glass Co., Ardagh Group S.A., Sisecam Group, Beatson Clark, and DWK Life sciences. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Global Pharmaceutical Glass Packaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Glass Packaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC20292

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Glass Packaging Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Growing pharmaceutical industry driving demand for packaging
  - 3.2.1.2. Superior safety and reliability of glass packaging
  - 3.2.1.3. Increasing market for biologics favoring glass due to compatibility
- 3.2.2. Restraints
  - 3.2.2.1. Higher cost compared to plastic alternatives
  - 3.2.2.2. Susceptibility to breakage during transportation and handling
  - 3.2.2.3. Environmental sustainability concerns related to energy-intensive production
- 3.2.3. Opportunities
  - 3.2.3.1. Advancements in lightweight glass formulations and handling technologies
  - 3.2.3.2. Focus on developing recyclable or biodegradable glass materials
  - 3.2.3.3. Expansion opportunities in emerging pharmaceutical markets
- 3.2.4. Challenges
  - 3.2.4.1. Volatility in raw material prices, such as silica sand
  - 3.2.4.2. Compliance with stringent regulatory requirements
  - 3.2.4.3. Competition from advancing plastic packaging technologies
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Glass Packaging Market: Marketing Strategies

5. Global Pharmaceutical Glass Packaging Market Overview

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Billion)
5.2. Market Share and Forecast
- 5.2.1. By Material
  - 5.2.1.1. Type I
  - 5.2.1.2. Type II
  - 5.2.1.3. Type III
- 5.2.2. By Route of Administration
  - 5.2.2.1. Oral
  - 5.2.2.2. Parenteral
  - 5.2.2.3. Inhalation
  - 5.2.2.4. Others (Topical etc.)
- 5.2.3. By Product
  - 5.2.3.1. Vials
  - 5.2.3.2. Bottles
  - 5.2.3.3. Cartridges & Syringes
  - 5.2.3.4. Ampoules
- 5.2.4. By Drug Type
  - 5.2.4.1. Generic
  - 5.2.4.2. Branded
  - 5.2.4.3. Biologics
- 5.2.5. By Region
  - 5.2.5.1. North America
  - 5.2.5.2. Europe
  - 5.2.5.3. Asia Pacific (APAC)
  - 5.2.5.4. Latin America (LATAM)
  - 5.2.5.5. Middle East and Africa (MEA)

6. North America Pharmaceutical Glass Packaging Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
- 6.2.1. By Material
- 6.2.2. By Route of Administration
- 6.2.3. By Product
- 6.2.4. By Drug Type
- 6.2.5. By Country
  - 6.2.5.1. United States
  - 6.2.5.1.1. By Material
  - 6.2.5.1.2. By Route of Administration
  - 6.2.5.1.3. By Product
  - 6.2.5.1.4. By Drug Type
  - 6.2.5.2. Canada
  - 6.2.5.2.1. By Material
  - 6.2.5.2.2. By Route of Administration
  - 6.2.5.2.3. By Product
  - 6.2.5.2.4. By Drug Type

7. Europe Pharmaceutical Glass Packaging Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By Material
- 7.2.2. By Route of Administration
- 7.2.3. By Product
- 7.2.4. By Drug Type
- 7.2.5. By Country
  - 7.2.5.1. Germany
  - 7.2.5.1.1. By Material
  - 7.2.5.1.2. By Route of Administration
  - 7.2.5.1.3. By Product
  - 7.2.5.1.4. By Drug Type
  - 7.2.5.2. United Kingdom
  - 7.2.5.2.1. By Material
  - 7.2.5.2.2. By Route of Administration
  - 7.2.5.2.3. By Product
  - 7.2.5.2.4. By Drug Type
  - 7.2.5.3. Italy
  - 7.2.5.3.1. By Material
  - 7.2.5.3.2. By Route of Administration
  - 7.2.5.3.3. By Product
  - 7.2.5.3.4. By Drug Type
  - 7.2.5.4. France
  - 7.2.5.4.1. By Material
  - 7.2.5.4.2. By Route of Administration
  - 7.2.5.4.3. By Product
  - 7.2.5.4.4. By Drug Type
  - 7.2.5.5. Spain
  - 7.2.5.5.1. By Material
  - 7.2.5.5.2. By Route of Administration
  - 7.2.5.5.3. By Product
  - 7.2.5.5.4. By Drug Type
  - 7.2.5.6. Belgium
  - 7.2.5.6.1. By Material
  - 7.2.5.6.2. By Route of Administration
  - 7.2.5.6.3. By Product
  - 7.2.5.6.4. By Drug Type
  - 7.2.5.7. Russia
  - 7.2.5.7.1. By Material
  - 7.2.5.7.2. By Route of Administration
  - 7.2.5.7.3. By Product
  - 7.2.5.7.4. By Drug Type
  - 7.2.5.8. The Netherlands
  - 7.2.5.8.1. By Material
  - 7.2.5.8.2. By Route of Administration
  - 7.2.5.8.3. By Product
  - 7.2.5.8.4. By Drug Type
  - 7.2.5.9. Rest of Europe
  - 7.2.5.9.1. By Material
  - 7.2.5.9.2. By Route of Administration
  - 7.2.5.9.3. By Product
  - 7.2.5.9.4. By Drug Type

8. Asia Pacific Pharmaceutical Glass Packaging Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By Material
- 8.2.2. By Route of Administration
- 8.2.3. By Product
- 8.2.4. By Drug Type
- 8.2.5. By Country
  - 8.2.5.1. China
  - 8.2.5.1.1. By Material
  - 8.2.5.1.2. By Route of Administration
  - 8.2.5.1.3. By Product
  - 8.2.5.1.4. By Drug Type
  - 8.2.5.2. India
  - 8.2.5.2.1. By Material
  - 8.2.5.2.2. By Route of Administration
  - 8.2.5.2.3. By Product
  - 8.2.5.2.4. By Drug Type
  - 8.2.5.3. Japan
  - 8.2.5.3.1. By Material
  - 8.2.5.3.2. By Route of Administration
  - 8.2.5.3.3. By Product
  - 8.2.5.3.4. By Drug Type
  - 8.2.5.4. South Korea
  - 8.2.5.4.1. By Material
  - 8.2.5.4.2. By Route of Administration
  - 8.2.5.4.3. By Product
  - 8.2.5.4.4. By Drug Type
  - 8.2.5.5. Australia & New Zealand
  - 8.2.5.5.1. By Material
  - 8.2.5.5.2. By Route of Administration
  - 8.2.5.5.3. By Product
  - 8.2.5.5.4. By Drug Type
  - 8.2.5.6. Indonesia
  - 8.2.5.6.1. By Material
  - 8.2.5.6.2. By Route of Administration
  - 8.2.5.6.3. By Product
  - 8.2.5.6.4. By Drug Type
  - 8.2.5.7. Malaysia
  - 8.2.5.7.1. By Material
  - 8.2.5.7.2. By Route of Administration
  - 8.2.5.7.3. By Product
  - 8.2.5.7.4. By Drug Type
  - 8.2.5.8. Singapore
  - 8.2.5.8.1. By Material
  - 8.2.5.8.2. By Route of Administration
  - 8.2.5.8.3. By Product
  - 8.2.5.8.4. By Drug Type
  - 8.2.5.9. Vietnam
  - 8.2.5.9.1. By Material
  - 8.2.5.9.2. By Route of Administration
  - 8.2.5.9.3. By Product
  - 8.2.5.9.4. By Drug Type
  - 8.2.5.10. Rest of APAC
  - 8.2.5.10.1. By Material
  - 8.2.5.10.2. By Route of Administration
  - 8.2.5.10.3. By Product
  - 8.2.5.10.4. By Drug Type

9. Latin America Pharmaceutical Glass Packaging Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By Material
- 9.2.2. By Route of Administration
- 9.2.3. By Product
- 9.2.4. By Drug Type
- 9.2.5. By Country
  - 9.2.5.1. Brazil
  - 9.2.5.1.1. By Material
  - 9.2.5.1.2. By Route of Administration
  - 9.2.5.1.3. By Product
  - 9.2.5.1.4. By Drug Type
  - 9.2.5.2. Mexico
  - 9.2.5.2.1. By Material
  - 9.2.5.2.2. By Route of Administration
  - 9.2.5.2.3. By Product
  - 9.2.5.2.4. By Drug Type
  - 9.2.5.3. Argentina
  - 9.2.5.3.1. By Material
  - 9.2.5.3.2. By Route of Administration
  - 9.2.5.3.3. By Product
  - 9.2.5.3.4. By Drug Type
  - 9.2.5.4. Peru
  - 9.2.5.4.1. By Material
  - 9.2.5.4.2. By Route of Administration
  - 9.2.5.4.3. By Product
  - 9.2.5.4.4. By Drug Type
  - 9.2.5.5. Rest of LATAM
  - 9.2.5.5.1. By Material
  - 9.2.5.5.2. By Route of Administration
  - 9.2.5.5.3. By Product
  - 9.2.5.5.4. By Drug Type

10. Middle East & Africa Pharmaceutical Glass Packaging Market

10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
- 10.2.1. By Material
- 10.2.2. By Route of Administration
- 10.2.3. By Product
- 10.2.4. By Drug Type
- 10.2.5. By Country
  - 10.2.5.1. Saudi Arabia
  - 10.2.5.1.1. By Material
  - 10.2.5.1.2. By Route of Administration
  - 10.2.5.1.3. By Product
  - 10.2.5.1.4. By Drug Type
  - 10.2.5.2. UAE
  - 10.2.5.2.1. By Material
  - 10.2.5.2.2. By Route of Administration
  - 10.2.5.2.3. By Product
  - 10.2.5.2.4. By Drug Type
  - 10.2.5.3. Qatar
  - 10.2.5.3.1. By Material
  - 10.2.5.3.2. By Route of Administration
  - 10.2.5.3.3. By Product
  - 10.2.5.3.4. By Drug Type
  - 10.2.5.4. Kuwait
  - 10.2.5.4.1. By Material
  - 10.2.5.4.2. By Route of Administration
  - 10.2.5.4.3. By Product
  - 10.2.5.4.4. By Drug Type
  - 10.2.5.5. South Africa
  - 10.2.5.5.1. By Material
  - 10.2.5.5.2. By Route of Administration
  - 10.2.5.5.3. By Product
  - 10.2.5.5.4. By Drug Type
  - 10.2.5.6. Nigeria
  - 10.2.5.6.1. By Material
  - 10.2.5.6.2. By Route of Administration
  - 10.2.5.6.3. By Product
  - 10.2.5.6.4. By Drug Type
  - 10.2.5.7. Algeria
  - 10.2.5.7.1. By Material
  - 10.2.5.7.2. By Route of Administration
  - 10.2.5.7.3. By Product
  - 10.2.5.7.4. By Drug Type
  - 10.2.5.8. Rest of MEA
  - 10.2.5.8.1. By Material
  - 10.2.5.8.2. By Route of Administration
  - 10.2.5.8.3. By Product
  - 10.2.5.8.4. By Drug Type

11. Competitive Landscape

11.1. List of Key Players and Their Offerings
11.2. Global Pharmaceutical Glass Packaging Market Share Analysis, 2023
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

13.1. Corning Incorporated
13.2. Nipro Corporation
13.3. Shandong Medicinal Glass Co., Ltd
13.4. Bormioli Pharma S.p.A.
13.5. Owens-Illinois, Inc.
13.6. SGD S.A.
13.7. Stoelzle Oberglas GmbH
13.8. Gerresheimer AG
13.9. West Pharmaceutical Services, Inc.
13.10. Piramal Enterprises Ltd
13.11. Arab Pharmaceutical Glass Co.
13.12. Ardagh Group S.A.
13.13. Sisecam Group
13.14. Beatson Clark
13.15. DWK Life sciences
13.16. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable